On the basis that absence of bacterial infections would induce minimal elevations in inflammatory markers, we sought to test the hypothesis that in COVID-19, low PCT concentrations could be predicted from low CRP or WCC values, thus informing cost-effective PCT testing algorithms in the routine clinical care of COVID-19. The gene discussed is CRP; the disease is COVID-19.